Longitudinal amyloid cognitive composite in preclinical Alzheimer's disease.

Young Ju KimAlice HahnYu Hyun ParkDuk L NaJuhee ChinSang Won Seo

Published in: European journal of neurology (2022)

The LACPA may contribute to reduction in time and financial burden when monitoring Aβ-related cognitive decline and therapeutic efficacy of the disease-modifying agents specifically targeting Aβ in secondary prevention trials.

Keyphrases

cognitive decline
mild cognitive impairment
cancer therapy
cross sectional
risk factors
healthcare
stem cells
affordable care act
mesenchymal stem cells
health insurance